Clinical trialPhase 2
AV-1959R vaccine in preclinical Alzheimer’s disease
NCT07827768
160 участников 55–80 лет, когнитивно сохранных, с биомаркерными признаками preclinical AD; randomized double-blind placebo-controlled.
No news refers to this card yet.
Also in the catalogue
- REGEND001 in emphysematous COPDClinical trial
- IB1001-303 (levacetylleucine in ataxia-telangiectasia)Clinical trial
- First-in-human: autologous bone-marrow MSC infusion in severe osteoporosisClinical trial
- Urolithin A vs placebo (NIA)Clinical trial
- Finerenone vs placebo in premature ovarian insufficiencyClinical trial
- PIEZO-101 (Piezo Therapeutics)Clinical trial
Scales
Identifiers
- NCT
- NCT07827768
Original sources
Details
- Phase
- Phase 2
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.